Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice.

Labrie V, Duffy S, Wang W, Barger SW, Baker GB, Roder JC.

Learn Mem. 2008 Dec 30;16(1):28-37. doi: 10.1101/lm.1112209. Print 2009 Jan.

2.

Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.

Karlsson RM, Tanaka K, Saksida LM, Bussey TJ, Heilig M, Holmes A.

Neuropsychopharmacology. 2009 May;34(6):1578-89. doi: 10.1038/npp.2008.215. Epub 2008 Dec 10.

3.

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.

Basu AC, Tsai GE, Ma CL, Ehmsen JT, Mustafa AK, Han L, Jiang ZI, Benneyworth MA, Froimowitz MP, Lange N, Snyder SH, Bergeron R, Coyle JT.

Mol Psychiatry. 2009 Jul;14(7):719-27. doi: 10.1038/mp.2008.130. Epub 2008 Dec 9. Erratum in: Mol Psychiatry. 2010 Nov;15(11):1122.

4.

Hypothalamic preproghrelin gene expression is repressed by insulin via both PI3-K/Akt and ERK1/2 MAPK pathways in immortalized, hypothalamic neurons.

Fick LJ, Cai F, Belsham DD.

Neuroendocrinology. 2009;89(3):267-75. doi: 10.1159/000167698. Epub 2008 Oct 29.

PMID:
18957841
5.

Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.

Labrie V, Clapcote SJ, Roder JC.

Pharmacol Biochem Behav. 2009 Feb;91(4):610-20. doi: 10.1016/j.pbb.2008.09.016. Epub 2008 Oct 7.

PMID:
18940194
6.

Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).

Ohnuma T, Sakai Y, Maeshima H, Hatano T, Hanzawa R, Abe S, Kida S, Shibata N, Suzuki T, Arai H.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1905-12. doi: 10.1016/j.pnpbp.2008.07.022. Epub 2008 Sep 16.

PMID:
18835577
7.

Recombinant human serine racemase: enzymologic characterization and comparison with its mouse ortholog.

Hoffman HE, Jirásková J, Ingr M, Zvelebil M, Konvalinka J.

Protein Expr Purif. 2009 Jan;63(1):62-7. doi: 10.1016/j.pep.2008.09.003. Epub 2008 Sep 11.

PMID:
18812225
8.

Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse.

Boutros PC, Yan R, Moffat ID, Pohjanvirta R, Okey AB.

BMC Genomics. 2008 Sep 16;9:419. doi: 10.1186/1471-2164-9-419.

9.

Trends in large-scale mouse mutagenesis: from genetics to functional genomics.

Gondo Y.

Nat Rev Genet. 2008 Oct;9(10):803-10. doi: 10.1038/nrg2431. Review.

PMID:
18781157
10.

Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.

Labrie V, Lipina T, Roder JC.

Psychopharmacology (Berl). 2008 Oct;200(2):217-30. doi: 10.1007/s00213-008-1196-6. Epub 2008 Jul 3.

PMID:
18597079
11.

D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration.

Wolosker H, Dumin E, Balan L, Foltyn VN.

FEBS J. 2008 Jul;275(14):3514-26. doi: 10.1111/j.1742-4658.2008.06515.x. Review.

12.

Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?

Chan RC, Gottesman II.

Neurosci Biobehav Rev. 2008 Jul;32(5):957-71. doi: 10.1016/j.neubiorev.2008.01.005. Epub 2008 Mar 19. Review.

PMID:
18462797
13.

Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.

Madeira C, Freitas ME, Vargas-Lopes C, Wolosker H, Panizzutti R.

Schizophr Res. 2008 Apr;101(1-3):76-83. doi: 10.1016/j.schres.2008.02.002. Epub 2008 Apr 2.

PMID:
18378121
14.
15.

Effect of MK-801 on gene expressions in the amygdala of rats.

Matsuoka T, Tsunoda M, Sumiyoshi T, Takasaki I, Tabuchi Y, Seo T, Tanaka K, Uehara T, Itoh H, Suzuki M, Kurachi M.

Synapse. 2008 Jan;62(1):1-7.

PMID:
17948890
16.

D-serine regulates CREB phosphorylation induced by NMDA receptor activation in Müller glia from the retina.

Lamas M, Lee-Rivera I, Ramírez M, López-Colomé AM.

Neurosci Lett. 2007 Oct 29;427(1):55-60. Epub 2007 Sep 15.

PMID:
17920195
17.

Beta N-acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression-like phenotype in mice.

Soleimani L, Roder JC, Dennis JW, Lipina T.

Genes Brain Behav. 2008 Apr;7(3):334-43. Epub 2007 Sep 18.

18.

D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.

Sasabe J, Chiba T, Yamada M, Okamoto K, Nishimoto I, Matsuoka M, Aiso S.

EMBO J. 2007 Sep 19;26(18):4149-59. Epub 2007 Aug 30.

19.

In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.

Adage T, Trillat AC, Quattropani A, Perrin D, Cavarec L, Shaw J, Guerassimenko O, Giachetti C, Gréco B, Chumakov I, Halazy S, Roach A, Zaratin P.

Eur Neuropsychopharmacol. 2008 Mar;18(3):200-14. Epub 2007 Aug 2.

PMID:
17681761
20.

Supplemental Content

Support Center